eMJA: An unusual cause of severe metabolic acidosis

Corrections

An unusual cause of severe metabolic acidosis

John V Peter, Natasha Rogers, Shailesh Murty, Rosemarie Gerace, Richard Mackay and Sandra L Peake

MJA 2006; 185 (9): 528

Re: “An unusual cause of severe metabolic acidosis”, by John V Peter, Natasha Rogers, Shailesh Murty, Rosemarie Gerace, Richard Mackay and Sandra L Peake, in the 21 August issue of the Journal (Med J Aust 2006; 185: 223-225). During the production process, the drug name “timentin” was inadvertently changed to “timolol”.

The sentence describing antibiotic therapy should read: “On Day 14, ceftriaxone and gentamicin were changed to empirical clavulanate/ticarcillin (Timentin, GlaxoSmithKline, Australia) and ciprofloxacin because of persistent fever and rising WCC.”

The html and pdf versions of the article were corrected on 29 August 2006.

Author details John V Peter, MD, DNB, FRACP, Reader1Natasha Rogers, MB BS, Registrar, Renal Medicine2Shailesh Murty, MB BS, MD, Registrar, Intensive Care Unit2Rosemarie Gerace, BSc, Scientist, Newborn Screening Unit3Richard Mackay, FRACP, Registrar3Sandra L Peake, BM BS, FJFICM, PhD, Senior Consultant, Intensive Care Unit2

1 Medical Intensive Care Unit, Christian Medical College and Hospital, Vellore, Tamil Nadu, INDIA.

2 Queen Elizabeth Hospital, Adelaide, SA.

3 Women's and Children's Hospital, Adelaide, SA.

Correspondence: peterjohnvictorATyahoo.com.au

(Received 2 Dec 2005, accepted 11 May 2006)